Clinical Trials Logo

Filter by:
NCT ID: NCT02143791 Completed - Chronic Pain Clinical Trials

Evaluate St Jude Medical Prodigy Neuromodulation for FBSS or Chronic Pain of the Trunk and/or Limbs

Prodigy-I
Start date: June 2014
Phase: N/A
Study type: Observational

The purpose of this study is to confirm long term efficacy and safety of the ProdigyTM neuromodulation system in the management of failed back surgery syndrome or chronic intractable pain of the trunk and/or limbs.

NCT ID: NCT02143310 Completed - Healthy Volunteers Clinical Trials

A Study to Evaluate the Safety of Electronic Vapor Products for 2 Years

Start date: May 2014
Phase: N/A
Study type: Interventional

Electronic Vapour Products (EVPs) is a relatively new class of consumer products that are otherwise known as electronic cigarettes devices/systems. These may look like conventional cigarettes but do not contain tobacco. The 'vapour' produced by such devices typically consists of humectants (propylene glycol or glycerol), nicotine, water, and flavours. This trial is to evaluate the safety and tolerability of an EVP over two years.

NCT ID: NCT02142920 Completed - Healthy Clinical Trials

Investigation Of The Metabolism, And Excretion Of [14c]-PF-05212384 In Healthy Male Volunteers

Start date: July 2014
Phase: Phase 1
Study type: Interventional

The purpose of the study is to characterize how PF-05212384 is metabolized in the body following a single intravenous dose of radioactively labeled drug ([14C]-PF-05212384).

NCT ID: NCT02142855 Completed - Healthy Clinical Trials

Structural and Metabolic Determinants of Sarcopenia and the Efficacy of Concentric vs. Eccentric Exercise Training

Start date: May 2014
Phase: N/A
Study type: Interventional

The first goal of this study is the follow young and older people over a period of 8 weeks to define the processes responsible for loss of muscle length and width in age-related muscle wasting (sarcopenia) and allow us to look at age-related differences in tendon. Secondly, we will assess two different exercise interventions for reversing human sarcopenia; one which involves shortening of the muscle and the other which involves lengthening, whilst also studying why these exercises work the way they do. This project will have significant implications for our understanding of the control of skeletal muscle and tendon size in humans, particularly in relation to sarcopenia and the surrounding health issues.

NCT ID: NCT02142816 Completed - Colorectal Surgery Clinical Trials

Fluid Requirement During Surgery PVI v Doppler

PVIvDoppler
Start date: January 2013
Phase: N/A
Study type: Interventional

Targeting the amount of fluid given to measurements of the patients own fluid status during major abdominal surgery has been linked with improved speed of recovery of gut function and reduced length of hospital stay, mortality and complications. Pleth variability index (PVI) offers a noninvasive, risk and pain free alternative to more invasive forms of monitoring to direct how much fluid to give. The study aims primarily to measure and compare how much fluid is given when guided by PVI compared to the established technique; oesophageal doppler during major abdominal surgery. The study will compare 40 patients undergoing major elective abdominal surgery. Patients will receive intraoperative fluid guided by either oesophageal doppler or PVI. Secondarily, the study will examine biochemical markers, length of hospital stay and how frequently complications occur

NCT ID: NCT02142478 Completed - Physical Activity Clinical Trials

Evaluation of Two Different Delivery Approaches of a GP Exercise Referral Scheme

Start date: May 2014
Phase: N/A
Study type: Observational

Physical activity (PA) benefits both physical and psychological health, yet the majority of UK adults are physically inactive. "Exercise for Health" (EFH) is a General Practitioner (GP) exercise referral scheme run in Liverpool for people who are inactive with a medical condition. Patients are referred by their GP practice, where they receive 12 weeks of subsidised exercise classes at their local leisure or community centre. In 2012, one of the thirteen EFH centres (Centre A) introduced some changes to try and improve EFH at their centre. These changes included: - a pre-scheme meeting with a health trainer, to help the patient decide if EFH is for them. - exclusive classes (gym or activities) available daily for EFH participants (compared to gym only classes two or three times a week in other centres). This non-randomised study will compare the effectiveness of the adapted EFH (Centre A) with standard EFH delivery (Centre B). All participants referred to centre A (n=100 approx) or centre B (n=100 approx) during the study period will be invited to take part. Changes in self-reported PA, PA self-efficacy and psychological wellbeing will be measured at the end of EFH (12 weeks) and at 12-month follow-up. A subsample of participants (n=15 from each centre) will take part in qualitative interviews to explore the factors that contribute to effectiveness. A secondary aim is to explore psychological factors contributing to any differences between the two centres. Self-determination theory suggests that where participants feel they are offered choice, feel they are competent at exercise, and feel connected to people they exercise with, they will be more intrinsically motivated and more likely to continue exercising. Therefore it is hypothesised that participants attending the adapted EFH will be more motivated and more likely to continue exercising.

NCT ID: NCT02142400 Completed - Anaemia Clinical Trials

Multiple Ascending Dose Study of DS-1093 in Healthy Subjects

Start date: May 2014
Phase: Phase 1
Study type: Interventional

This is a randomised, double-blind, placebo-controlled multiple ascending single study. It is hypothesised that at least dose of DS-1093a will be safe and tolerable over a 2-week treatment period and will result in increases in reticulocyte count and haemoglobin concentrations in healthy male volunteers

NCT ID: NCT02142153 Completed - Clinical trials for Invasive Aspergillosis

F901318 Single Ascending Dose Study in Healthy Male Volunteers

Start date: August 2014
Phase: Phase 1
Study type: Interventional

F901318 is a potent new antifungal agent for the treatment of systemic fungal infections. This study will test it for the first time in man with the objective of assessing its safety, tolerability and pharmacokinetic profile.

NCT ID: NCT02142062 Completed - Clinical trials for Iliac Venous Compression

Venogram vs. Intravascular Ultrasound (IVUS) for Diagnosing Iliac Vein Obstruction

VIDIO
Start date: July 2014
Phase: N/A
Study type: Observational

The purpose of this study is to demonstrate that IVUS identifies more instances of significant iliac and common femoral vein outflow obstruction than multiplanar venography.No hypothesis testing is planned.

NCT ID: NCT02141802 Completed - Cerebral Palsy Clinical Trials

Clinical Effectiveness of Increased Standing Time in Non-ambulant Children With Cerebral Palsy:a Pilot Study

Start date: May 1, 2014
Phase: N/A
Study type: Interventional

Children with cerebral palsy commonly use standing frames to position them to help prevent contracture and deformity and to help their function. There is a lack of evidence to support the correct dosage of standing frame use. The aim of this study is to pilot a randomised controlled trial of the clinical effects of doubling the duration of standing, using standing frames, in young children who are unable to walk, who have cerebral palsy or developmental delay. It will determine whether it is feasable to carry out a multi-centred trial. The study objectives will be to determine: 1. presence of adverse events 2. recruitment and drop out rate 3. compliance with the intervention 4. feasibility of the randomisation and minimisation process 5. the proportion of the outcome measures taken 6. effect size estimate 7. required study costs 8. effectiveness of blinding procedure